Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ghosn

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Bulletin Du Cancer|January 1, 1990
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)]D Baume, J L Pico, J P Droz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
Super-high-risk germ-cell tumors: a clinical entity. Report of eleven casesA Moran-Ribon, J P Droz, J Kattan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancerJ P Droz, J L Pico, M Ghosn, et al.
Cancer|July 1, 1988
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimenM Ghosn, J P Droz, C Theodore, et al.
Diagnostic and Interventional Imaging|October 5, 2020
Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteriaM Ghosn, H Derbel, R Kharrat, et al.
Cancer|August 1, 1988
Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysisJ P Droz, A Kramar, M Ghosn, et al.
Progress in Clinical and Biological Research|January 1, 1990
Phase II trial of pre- and postoperative cisplatin, methotrexate and vinblastine in infiltrating bladder cancer: a three year experienceJ P Droz, M B Azab, C Theodore, et al.
Journal of Cancer Research and Clinical Oncology|January 21, 2023
Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trialK Alsaleh, H Al Zahwahry, A Bounedjar, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Bulletin Du Cancer|January 1, 1990
[Value of high-dose chemotherapy followed by bone marrow autograft in non-seminomatous germinal tumor with poor prognosis. Results of the combination of cisplatinum, etoposide and cyclophosphamide (PEC protocol)]D Baume, J L Pico, J P Droz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1994
Super-high-risk germ-cell tumors: a clinical entity. Report of eleven casesA Moran-Ribon, J P Droz, J Kattan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancerJ P Droz, J L Pico, M Ghosn, et al.
Cancer|July 1, 1988
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimenM Ghosn, J P Droz, C Theodore, et al.
Diagnostic and Interventional Imaging|October 5, 2020
Prediction of overall survival in patients with hepatocellular carcinoma treated with Y-90 radioembolization by imaging response criteriaM Ghosn, H Derbel, R Kharrat, et al.
Cancer|August 1, 1988
Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysisJ P Droz, A Kramar, M Ghosn, et al.
Progress in Clinical and Biological Research|January 1, 1990
Phase II trial of pre- and postoperative cisplatin, methotrexate and vinblastine in infiltrating bladder cancer: a three year experienceJ P Droz, M B Azab, C Theodore, et al.
Journal of Cancer Research and Clinical Oncology|January 21, 2023
Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trialK Alsaleh, H Al Zahwahry, A Bounedjar, et al.
Pageof 6